New Evidence that the Immune System Can Be Activated in Parkinson’s

Date
Author
Parkinson's Foundation

All Science News articles summarize a research study and are not an official opinion, endorsement or position of the Parkinson’s Foundation’s.

A new study funded in part by the Parkinson’s Foundation shows how the loss of brain neurons in Parkinson’s disease (PD) could, in part, result from an attack by a person’s own immune system.  Furthermore, the researchers link this attack to alpha-synuclein – the protein that forms toxic clumps in the brain cells of people with PD.  The results appear in the June 21 online edition of Nature.

Category
Science News

Drug Targeting Toxic Alpha-Synuclein Is Found Safe in Early Clinical Trial

Date
Author
Parkinson's Foundation

In an early, small clinical trial an experimental drug designed to clear away a toxic protein associated with Parkinson’s disease (PD) was found to be safe in people. This result is a step toward evaluating whether therapies that target the alpha-synuclein protein can slow PD progression.  The research appears in the February edition of Movement Disorders.

Category
Science News

Key Enzyme Regulates Brain Cell Change in Parkinson’s

Date
Author
Parkinson's Foundation

In studies with laboratory mice, scientists have identified a single molecule, an enzyme called c-Abl, that regulates the build-up of toxic alpha-synuclein protein in brain cells. Such protein clumps, known as Lewy bodies, are the hallmark of Parkinson’s disease (PD). The finding suggests that blocking the enzyme may be an effective approach for new therapies to treat PD. The research appears in the June 27 online edition of The Journal of Clinical Investigation.

Category
Science News

Molecule that Targets Alpha-Synuclein Points Toward Potential Parkinson’s Therapy

Date
Author
Parkinson's Foundation

In laboratory studies with cells, scientists have identified a new molecule that may be able to help clear toxic protein clumps from the brain in Parkinson’s disease (PD). Its discovery begins a long road of research that potentially lead to a new therapy for PD. The study appears in the July 13 edition of The Journal of Neuroscience.

Category
Science News
X
 

Sign Up for Our E-Newsletter

Get the latest news about PD research, resources and community initiatives – straight to your inbox.

Please enter a valid email

Skip step



Invalid year format. Eg: 2020
Skip step
Skip step


*Please note that not all content is available in both languages. If you are interested in receiving Spanish communications, we recommend selecting “both" to stay best informed on the Foundation's work and the latest in PD news.

Skip step

Thanks for Signing Up

We are proud to have you as a part of our community. To ensure you receive the latest Parkinson’s news, research updates and more, please check your email for a message from us. If you do not see our email, it may be in your spam folder. Just mark as “not spam” and you should receive our emails as expected.

mail icon

Subscribe here to get the latest news on treatments, research and other updates.